Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-08-04Clinical Trial Update: Ketamine for Treatment of MS Fatigue [Phase 1, Phase 2]
Clinical trial update on ketamine for fatigue in multiple sclerosis, with Phase 1 and Phase 2 completed and results posted in 2020.
-
FDA approval · 2020-07-31FDA Approved: MAYZENT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Mayzent (siponimod) submitted by Novartis Pharmaceuticals Corporation. The submission is for NDA…
-
CLINICAL_TRIALS trial_result · 2020-07-28Clinical Trial Update: Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis [Phase 2]
Phase 2 trial update on ibudilast in progressive multiple sclerosis assessing safety, tolerability, and activity.
-
FDA approval · 2020-07-22FDA Approved: COPAXONE — Supplemental Application (Teva Neuroscience, Inc.)
FDA approved a supplemental application for COPAXONE (glatiramer acetate) by Teva Neuroscience, Inc., leading to changes to the drug’s label…
-
CLINICAL_TRIALS trial_result · 2020-07-20Clinical Trial Update: Collection of Blood Samples From Patients With Relapsing MS Who Developed ITP After Receiving Lemtrada [Phase 4]
Phase 4 trial update collecting blood samples from relapsing MS patients who developed ITP after Lemtrada; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-07-18FDA Approved: TERIFLUNOMIDE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for teriflunomide from Alembic Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Neuroproprioceptive "Facilitation, Inhibition" and Brain Plasticity [NA]
A completed clinical trial conducted by Charles University investigating neuroproprioceptive facilitation and inhibition and brain plasticit…
-
FDA approval · 2020-07-09FDA Approved: BACLOFEN — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved an original application for a generic baclofen product from Unichem Pharmaceuticals (USA), Inc.
-
FDA approval · 2020-07-02FDA Approved: FINGOLIMOD — Original Application (Teva Pharmaceuticals, Inc.)
The FDA approved Teva's original application for a generic fingolimod product (ANDA 208008). Fingolimod is used to treat relapsing forms of …
-
CLINICAL_TRIALS trial_result · 2020-06-29Clinical Trial Update: A TSEC for Symptom Management in Menopausal Women With Multiple Sclerosis [Phase 2]
Phase 2 trial investigating a targeted estrogen-based therapy (TSEC) for symptom management in menopausal women with multiple sclerosis; res…
-
CLINICAL_TRIALS trial_result · 2020-06-29Clinical Trial Update: A Study to Evaluate the Safety of Administering Ocrelizumab Per a Shorter Infusion Protocol in Participants With Primary Progressive Multiple Sclerosis (PPMS) and Relapsing Multiple Sclerosis (RMS) [Phase 3]
Phase 3 clinical trial evaluating a shorter infusion protocol for ocrelizumab in primary progressive and relapsing multiple sclerosis has co…
-
FDA approval · 2020-06-23FDA Approved: TERIFLUNOMIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic teriflunomide from Aurobindo Pharma Limited, enabling its marketing for multiple scler…
-
FDA approval · 2020-06-22FDA Approved: TERIFLUNOMIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for teriflunomide from Mylan Pharmaceuticals Inc., enabling a generic version to be marketed.
-
FDA approval · 2020-06-18FDA Approved: FINGOLIMOD — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark's original application for fingolimod, allowing a generic version of the multiple sclerosis treatment to reach the mar…
-
FDA approval · 2020-06-17FDA Approved: TYSABRI — Supplemental Application (Biogen Inc.)
FDA supplemental approval application submitted for TYSABRI (natalizumab) by Biogen; seeks regulatory action on an additional indication or …
-
FDA approval · 2020-05-27FDA Approved: TIZANIDINE HYDROCHLORIDE — Original Application (Trifluent Pharma, LLC)
FDA approved the original application for tizanidine hydrochloride from Trifluent Pharma, LLC as a generic drug.
-
FDA approval · 2020-05-26FDA Approved: REBIF — Supplemental Application (EMD Serono, Inc.)
FDA approved a supplemental application for REBIF (interferon beta-1a) submitted by EMD Serono, Inc.
-
FDA approval · 2020-05-18FDA Approved: FINGOLIMOD — Original Application (XLCare Pharmaceuticals Inc.)
FDA approved Fingolimod from XLCare Pharmaceuticals Inc. as an original-application generic for relapsing forms of multiple sclerosis.
-
FDA label_change · 2020-05-15FDA Approved: OCREVUS — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Ocrevus (ocrelizumab) from Genentech, Inc., resulting in labeling changes for its multiple scler…
-
FDA approval · 2020-05-14FDA Approved: COPAXONE — Supplemental Application (Teva Neuroscience, Inc.)
The FDA approved a supplemental application for COPAXONE (glatiramer acetate) submitted by Teva Neuroscience, Inc.
-
CLINICAL_TRIALS trial_result · 2020-05-08Clinical Trial Update: Pilot Study of Transcranial Direct Current Stimulation (tDCS) [NA]
A completed pilot study evaluating transcranial direct current stimulation (tDCS) for multiple sclerosis; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-05-08Clinical Trial Update: Muscle Vibration in MS to Improve Walking [NA]
Clinical trial update for a study on muscle vibration to improve walking in people with multiple sclerosis has been terminated with results …
-
CLINICAL_TRIALS research · 2020-04-20Clinical Trial Update: Carnosine Loading and Periodized Training in MS and HC [NA]
Clinical trial update on carnosine loading and periodized training in people with multiple sclerosis and healthy controls; results posted af…
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of masitinib in progressive multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-07Clinical Trial Update: Pilot Study of Powered Exoskeleton Use for Gait Rehabilitation in Individuals With Multiple Sclerosis [NA]
A completed pilot trial evaluating powered exoskeletons for gait rehabilitation in individuals with multiple sclerosis.